Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 3,320 shares at $85.21 ($283K) on 2020-05-12, disclosed to the SEC on 2020-05-14.
Seasonal sale ($283k) by Director — this insider has traded EBS in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.21 | 1,660 | $141K | 50.0% |
| 2 | $85.21 | 1,660 | $141K | 50.0% |
| Total | $85.21 avg | 3,320 | $283K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |